微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.68% | -18.58% | 25.6% | 41/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 2.93% | -12.8% | -65.73% | 24/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 8.55% | -21.56% | -6.35% | 27/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 9.13% | -21.09% | 101.99% | 22/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 4.52% | -28.48% | 34.52% | 33/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 3.36% | -22.58% | -69.17% | 15/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 10.9% | -18.54% | -5.79% | 24/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 11.57% | -8.97% | 83.07% | 15/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 6.32% | 3.61% | 45.62% | 23/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 4.34% | 8.23% | -67.56% | 12/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 13.38% | -42.08% | 5.27% | 20/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 12.71% | -26.53% | 108.36% | 10/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 6.1% | -39.84% | 52.12% | 35/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 4.01% | -37.93% | -82.64% | 25/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 23.1% | -7.19% | 33.53% | 19/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 17.3% | -19.31% | 70.61% | 27/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 10.14% | -4.88% | 56.97% | 34/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 6.46% | -14.89% | -74.05% | 23/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 24.89% | -3.6% | 16.09% | 27/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 21.44% | 33.83% | 101.13% | 20/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 10.66% | 33.92% | 40.45% | 44/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 7.59% | 171.07% | -70.6% | 20/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 25.82% | 13.49% | 61.17% | 35/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 16.02% | -20.58% | 101.26% | 36/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 7.96% | -11.95% | 184.29% | 52/141 | 15.17% | 杭州博拓生物科技 | 108.13% | 行业排名> |
| 2020-03-31 | 2.8% | -41.54% | -87.69% | 29/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 22.75% | 9.96% | 12.79% | 30/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 20.17% | 7.57% | 123.12% | 12/141 | 10.54% | 祥生医疗科技 | 28.56% | 行业排名> |
| 2019-06-30 | 9.04% | 9.18% | 88.73% | 18/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 4.79% | 11.4% | -76.85% | 9/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 20.69% | 8.04% | 10.35% | 29/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 18.75% | 12.88% | 126.45% | 5/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 8.28% | -3.16% | 92.56% | 13/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 4.3% | -9.66% | -77.55% | 12/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 19.15% | -45.57% | 15.29% | 31/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 16.61% | -38.32% | 94.27% | 5/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 8.55% | -39.53% | 79.62% | 16/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 4.76% | 2% | -86.47% | 4/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 35.18% | -4.06% | 30.63% | 9/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 26.93% | 2% | 90.45% | 2/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 14.14% | 2% | -61.44% | 7/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |